Souhaitez-vous accéder aux communiqués récents ?

Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer

The Global Virus Network believes that systemic inadequacies and vulnerabilities persist, which threaten public health on a global scale.

GVN calls on world governments to address the threat of H5N1 avian influenza by enhancing surveillance, implementing biosecurity measures, and preparing

Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "U.S. Biodefense Market Size, Share & Trends Analysis Report by Product (Anthrax, Small Pox, Botulism, Radiation/nuclear), and Segment Forecasts,...

BRISBANE, Australia, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trellis Data, a leading provider of AI-driven solutions, together with the Australian Department of Agriculture, Fisheries and Forestry (the...

West Conshohocken, PA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announced today that SERB will present in vivo data for PR022, a polyclonal antibody in development as...

BOSTON and NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Ginkgo Bioworks (NYSE: DNA) and XWELL, Inc. (Nasdaq: XWEL) today announced that they have expanded their support for the Centers for Disease...

BOSTON and NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Ginkgo Bioworks (NYSE: DNA) and XpresSpa Group, Inc. (Nasdaq: XSPA) announced they will continue to support the Centers for Disease Control and...

Pune, India, June 06, 2022 (GLOBE NEWSWIRE) -- The global biodefense market size is poised to grow at a significant CAGR during the forecast period, owing to the rising incidence of infectious...

WASHINGTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Synthetic biology is an area for scientific research that involves redesigning organisms for useful purposes by engineering them to have new abilities....